Quantitative differences in chromatin accessibility across regulatory regions can be directly compared in distinct cell-types

Biochemical and Biophysical Research Communications

Volumn 367, Issue 2, 2008, Pages 349-355

  Cruickshank, Mark ^a,b   Fenwick, Emily ^a,b   Abraham, Lawrence J ^a   Ulgiati, Daniela ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

B cell differentiation; CD21; Chromatin accessibility; Complement Receptor 2; Transcriptional activation

Indexed keywords

BETA ACTIN; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 2; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; MICROCOCCAL NUCLEASE; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN U937; CELL SURFACE; CELL TYPE; CHROMATIN; CONTROLLED STUDY; CR2 GENE; GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; RAJI CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION;

ANIMALS; CELL LINE; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; HUMANS; RECEPTORS, COMPLEMENT 3D; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SPECIES SPECIFICITY; TRANS-ACTIVATION (GENETICS);

EUKARYOTA;

EID: 38349051099     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.121     Document Type: Article

References (28)

1. Keene M.A., and Elgin S.C. Micrococcal nuclease as a probe of DNA sequence organization and chromatin structure. Cell 27 (1981) 57-64
2. Zinn K., and Maniatis T. Detection of factors that interact with the human beta-interferon regulatory region in vivo by DNAase I footprinting. Cell 45 (1986) 611-618
3. Rao S., Procko E., and Shannon M.F. Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J. Immunol. 167 (2001) 4494-4503
4. Rickert R.C. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr. Opin. Immunol. 17 (2005) 237-243
5. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., and Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271 (1996) 348-350
6. Takahashi K., Kozono Y., Waldschmidt T.J., Berthiaume D., Quigg R.J., Baron A., and Holers V.M. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J. Immunol. 159 (1997) 1557-1569
7. Tedder T.F., Clement L.T., and Cooper M.D. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J. Immunol. 133 (1984) 678-683
8. Syagailo Y.V., Okladnova O., Reimer E., Grassle M., Mossner R., Gattenlohner S., Marx A., Meyer J., and Lesch K.P. Structural and functional characterization of the human PAX7 5′-flanking regulatory region. Gene 294 (2002) 259-268
9. Madsen J., Tornoe I., Nielsen O., Koch C., Steinhilber W., and Holmskov U. Expression and localization of lung surfactant protein A in human tissues. Am. J. Respir. Cell Mol. Biol. 29 (2003) 591-597
10. Kim J.K., Kim S.S., Rha K.W., Kim C.H., Cho J.H., Lee C.H., Lee J.G., and Yoon J.H. Expression and localization of surfactant proteins in human nasal epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 292 (2007) L879-L884
11. Ulgiati D., and Holers V.M. CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor. J. Immunol. 167 (2001) 6912-6919
12. Makar K.W., Ulgiati D., Hagman J., and Holers V.M. A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation. Int. Immunol. 13 (2001) 657-664
13. Ulgiati D., Pham C., and Holers V.M. Functional analysis of the human complement receptor 2 (CR2/CD21) promoter: characterization of basal transcriptional mechanisms. J. Immunol. 168 (2002) 6279-6285
14. Guthridge J.M., Young K., Gipson M.G., Sarrias M.R., Szakonyi G., Chen X.S., Malaspina A., Donoghue E., James J.A., Lambris J.D., Moir S.A., Perkins S.J., and Holers V.M. Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface. J. Immunol. 167 (2001) 5758-5766
15. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
16. Down T.A., and Hubbard T.J. Computational detection and location of transcription start sites in mammalian genomic DNA. Genome Res. 12 (2002) 458-461
17. Mirzabekov A.D., Belyavsky A.V., Bavykin S.G., and Shick V.V. Primary organization of nucleosomes and its functional implications. Biosystems 12 (1980) 265-271
18. Li J., Gao E., Seidner S.R., and Mendelson C.R. Differential regulation of baboon SP-A1 and SP-A2 genes: structural and functional analysis of 5′-flanking DNA. Am. J. Physiol. 275 (1998) L1078-L1088
19. Danilition S.L., Frederickson R.M., Taylor C.Y., and Miyamoto N.G. Transcription factor binding and spacing constraints in the human beta-actin proximal promoter. Nucleic Acids Res. 19 (1991) 6913-6922
20. Nasrin N., Ercolani L., Denaro M., Kong X.F., Kang I., and Alexander M. An insulin response element in the glyceraldehyde-3-phosphate dehydrogenase gene binds a nuclear protein induced by insulin in cultured cells and by nutritional manipulations in vivo. Proc. Natl. Acad. Sci. USA 87 (1990) 5273-5277
21. Edelstein L.C., Pan A., and Collins T. Chromatin modification and the endothelial-specific activation of the E-selectin gene. J. Biol. Chem. 280 (2005) 11192-11202
22. Holloway A.F., Rao S., Chen X., and Shannon M.F. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins. J. Exp. Med. 197 (2003) 413-423
23. Chen X., Wang J., Woltring D., Gerondakis S., and Shannon M.F. Histone dynamics on the interleukin-2 gene in response to T-cell activation. Mol. Cell. Biol. 25 (2005) 3209-3219
24. Shoemaker J., Saraiva M., and O'Garra A. GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells. J. Immunol. 176 (2006) 3470-3479
25. Ahearn J.M., Fischer M.B., Croix D., Goerg S., Ma M., Xia J., Zhou X., Howard R.G., Rothstein T.L., and Carroll M.C. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4 (1996) 251-262
26. Marchbank K.J., Kulik L., Gipson M.G., Morgan B.P., and Holers V.M. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia. J. Immunol. 169 (2002) 3526-3535
27. Rayhel E.J., Dehoff M.H., and Holers V.M. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins. J. Immunol. 146 (1991) 2021-2026
28. Christensen S.M., Martin B.K., Tan S.S., and Weis J.H. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene. J. Immunol. 148 (1992) 3610-3617